Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2012 Nov;194(21):5959–5960. doi: 10.1128/JB.01268-12

Genome Sequence of the Lantibiotic Bacteriocin Producer Streptococcus salivarius Strain K12

Caroline Barretto a,, Pablo Alvarez-Martin a, Francis Foata a, Pierre Renault b, Bernard Berger a,
PMCID: PMC3486084  PMID: 23045482

Abstract

Streptococcus salivarius is a prevalent commensal species of the oropharyngeal tract. S. salivarius strain K12 is an isolate from the saliva of a healthy child, used as an oral probiotic. Here, we report its genome sequence, i.e., the full sequence of the 190-kb megaplasmid pSsal-K12 and a high-quality draft 2.2-Gb chromosomal sequence.

GENOME ANNOUNCEMENT

Streptococcus salivarius is an early colonizer of the human oral cavity and remains a prominent member of the oropharyngeal tract of “healthy” humans (13). S. salivarius is a heterogeneous species, and rare cases of strains associated with human infections have been reported (4, 16). Some commensal strains of S. salivarius are also used as probiotics for oral and upper respiratory tract health (9, 17, 18), since they are producers of a particularly diverse range of lantibiotic bacteriocins with a broad spectrum against several streptococcal pathogens (18).

Streptococcus salivarius strain K12 (Blis Technologies Ltd.) was isolated from the saliva of a healthy child (repository reference ATCC BAA-1024). It was reported to be a colonizer of the oral mucosa of infants and adults (11, 15), to be effective against halitosis (1), and to downregulate the innate immune responses of human epithelial cells (5). Its safety and human tolerance were also assessed (2, 3), and it received self-affirmed generally recognized as safe (GRAS) status from the United States Food and Drug Administration in 2011. Here, we make available its genome sequence, i.e., the full sequence of the megaplasmid coding for two salivaricins (12) and a high-quality draft chromosomal sequence.

The genome sequence of S. salivarius strain K12 was determined using the 454 GS-FLX sequencer (Roche Diagnostics) and Solexa HiSeq (Illumina, Inc.). The chromosome reads were assembled into 95 contigs with Newbler (14), providing 44-fold coverage. Contigs were aligned with the complete genome sequence of S. salivarius strain JIM8777 (8) using the mummer package (6). Gaps were closed by PCR, followed by Sanger sequencing of the products and primer walking. The K12 chromosome sequence currently comprises six contigs. The remaining genomic gaps contain copies of highly repetitive serine-rich motifs of putative transmembrane proteins. The estimated length of the chromosome is 2,241,913 bp, with a GC content of 38.9%. The length of the plasmid is 185,045 bp, with a GC content of 34.4%.

Automated annotation carried out by IG Assets using a proprietary pipeline revealed 6 rRNA operons and 57 tRNA genes. It indicated 2,089 protein-coding sequences (CDS) on the chromosome, of which 1,710 (82%) were annotated with known biological functions and 379 (18%) encode hypothetical proteins. The megaplasmid pSsal-K12 contains 164 CDS, of which 69 (42%) were annotated with known biological functions and 95 (68%) encode hypothetical proteins.

Comparative genomics within S. salivarius showed that out of 2,089 genes predicted on the chromosome of K12, 1,801, 1,777, and 1,760 align with the genome of the commensals JIM8777 (8) and M18 (10) and the clinical isolate CCHSS3 (7), respectively. Comparative analysis of pSsal-K12 and the only previously characterized S. salivarius megaplasmid, pSsal-M18, isolated from the probiotic strain M18 (10), revealed 54% alignment of the predicted genes. The high-quality draft genome sequence of this probiotic S. salivarius strain will contribute to our understanding of the role of this species in the oropharyngeal ecology of human health.

Nucleotide sequence accession numbers.

This whole-genome project has been deposited at DDBJ/EMBL/GenBank under the accession number ALIF00000000. The version described in this paper is the first version, ALIF01000000.

ACKNOWLEDGMENTS

We thank Jeremy Burton from Blis Technologies Ltd. for providing the strain and Deborah Moine for preparing the genomic DNA and for helpful discussions. We acknowledge Fasteris SA and 454 Life Sciences for performing the sequencing and IG Assets for performing the automatic annotation.

Nestlé and Blis Technologies have a research agreement.

This work was funded by Nestec Ltd.

REFERENCES

  • 1. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. 2006. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J. Appl. Microbiol. 100: 754– 764 [DOI] [PubMed] [Google Scholar]
  • 2. Burton JP, et al. 2011. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem. Toxicol. 49: 2356– 2364 [DOI] [PubMed] [Google Scholar]
  • 3. Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. 2006. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl. Environ. Microbiol. 72: 3050– 3053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Conte A, et al. 2006. Streptococcus salivarius meningitis and sphenoid sinus mucocele. Case report and literature review. J. Infect. 52: e27– e30 [DOI] [PubMed] [Google Scholar]
  • 5. Cosseau C, et al. 2008. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect. Immun. 76: 4163– 4175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Delcher AL, et al. 1999. Alignment of whole genomes. Nucleic Acids Res. 27: 2369– 2376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Delorme C, et al. 2011. Complete genome sequence of the clinical Streptococcus salivarius strain CCHSS3. J. Bacteriol. 193: 5041– 5042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Guedon E, et al. 2011. Complete genome sequence of the commensal Streptococcus salivarius strain JIM8777. J. Bacteriol. 193: 5024– 5025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Guglielmetti S, et al. 2010. Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl. Environ. Microbiol. 76: 3948– 3958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Heng NC, et al. 2011. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18. J. Bacteriol. 193: 6402– 6403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Horz HP, Meinelt A, Houben B, Conrads G. 2007. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction. Oral Microbiol. Immunol. 22: 126– 130 [DOI] [PubMed] [Google Scholar]
  • 12. Hyink O, et al. 2007. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl. Environ. Microbiol. 73: 1107– 1113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kazor CE, et al. 2003. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J. Clin. Microbiol. 41: 558– 563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Margulies M, et al. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376– 380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Power DA, Burton JP, Chilcott CN, Dawes PJ, Tagg JR. 2008. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur. J. Clin. Microbiol. Infect. Dis. 27: 1261– 1263 [DOI] [PubMed] [Google Scholar]
  • 16. Srinivasan V, et al. 2012. Using PCR-based detection and genotyping to trace Streptococcus salivarius meningitis outbreak strain to oral flora of radiology physician assistant. PLoS One 7: e32169 doi:10.1371/journal.pone.0032169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Tagg JR, Dierksen KP. 2003. Bacterial replacement therapy: adapting ‘germ warfare’ to infection prevention. Trends Biotechnol. 21:217– 223 [DOI] [PubMed] [Google Scholar]
  • 18. Wescombe PA, et al. 2006. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek 90: 269– 280 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES